Post Profile






The Bill Ackman problem everyone forgot is now at threat-level substantial

The insider trading case against Pershing Square founder Bill Ackman and Valeant Pharmaceuticals may go to trial. Investors in Allergan Pharmaceuticals are suing Ackman and Valeant over their hostile takeover of the company in 2014. There may be a Bill Ackman insider-trading trial on the way. You may recall that investors in Allergan Pharmaceuticals are suing the billionaire hedge fund manager and Valeant Pharmaceuticals over their 2014 attempt to buy Allergan in a hostile takeover.
read more

share
See more about: Bill Ackman Pershing Square

Related Posts


Allergan Shares Explode On Report Of Bill Ackman Takeover

Business & Finance : Business Insider: Clusterstock

Shares of pharmaceutical company Allergan are exploding in the after hours session. The stock (AGN) is up more than 19%. CNBC is reporting, via Dow Jones, that activist investor Bill Ackman of Pershing Square is teaming up with Vale...

Bill Ackman just took a $200 million hit to his reputation

Business & Finance : Business Insider: Clusterstock

Billionaire investor Bill Ackman and his firm Pershing Square, along with Valeant Pharmaceuticals, will pay just under $300 million to settle an insider-trading suit over their attempt to buy pharmaceutical firm Allergan in 2014. Ac...

LIVE: Bill Ackman defends his big money-losing bet in Valeant (VRX)

Business & Finance : Business Insider: Money Game

Billionaire activist investor Bill Ackman, founder of Pershing Square Capital, is hosting a conference call for investors to discuss his fund's large investment in Valeant Pharmaceuticals. Ackman and other Pershing Square portfolio ...

The Bill Ackman problem everyone forgot about is coming back to bite him and Valeant (VRX)

Business & Finance : Business Insider: Money Game

And now for some bad news for billionaire Bill Ackman, founder of hedge fund Pershing Square. Valeant Pharmaceuticals, the drug company whose 90% stock-price disaster has been dragging down Ackman's portfolio since October, announce...

Bill Ackman's Takeover Target Is Now Suing Him For Alleged Insider Trading

Business & Finance : Business Insider: Clusterstock

It's been a rough couple of weeks for Bill Ackman, and this news isn't going to make it any better. Ackman's hedge fund, Pershing Square, and pharmaceutical company Valeant are being sued for alleged insider trading by Allergan, the...

Comments


Copyright © 2016 Regator, LLC